Dr. Gert Veldhuis, CBO of U-Needle, will attend Bio-Europe Spring in Amsterdam on March 12-14, 2018. Please send us an email if you would like to meet up with him and learn more about U-Needle.
U-Needle develops proprietary hollow-microneedle technology applied in various user-friendly intradermal injection devices for vaccination, diabetes therapies and aesthetics.
Intradermal delivery facilitates effective immuno-activation, fast therapy onset and reduced dose in pharmaceutical injectables. Perpendicular injection with a very short needle provides full control of injection depth and reduced needle fear for the patient.
Please visite our website for further information.